References
  1. Haaksama ME, Heldeweg ML, Lpopez Matta et al. Lung ultrasound findings in patients with novel SARS-CoV2. medRxiv preprint https://doi.org/10.1101/2020.05.18.20105775
  2. Fox R, Akmatbekov A, Harbert J, Li G, Brown Q, Vander Heide RS. Pulmonary and cardiac Pathology in COVID -19; the first autopsy series from New Orleans. medRxiv. doi: 10.1101/2020.04.06.20050575
  3. Carsana L , Sonzsogni A, Nasr A et al. Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy https://doi.org/10.1101/2020.04.19.20054262.
  4. Franks TJ, Chong PY,Chui P et al. Lung pathology of severe acute respiratory syndrome (SARS ): a study of 8 autopsy cases from Singapore. Hum Pathol 2003;743-748. DOI: 10.1016/s0046-8177(03)00367-8
  5. Ackermann M, Verleden SE, Kuehnel M et al. Pulmonary Vascular Endothelialitis, Thrombosis, and angiogenesis in COVID-19. NEJM May 21 2020:DOI: 10.1056/NEJMoa2015432
  6. Wang Y, Dong C, Hu Y et al Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology Published Online: Mar 19 2020 https://doi.org/10.1148/radiol.2020200843.
  7. Brauer R, Chen P. Influenza leaves a Trail to pulmonary Oedema. J Clin Invest. 2016;126(4):1245–1247. doi:10.1172/JCI86802.
  8. Peteranderl C, et al. Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection. J Clin Invest 2016;126: 1566-1580 . doi.org/10.1172/JCI83931.
  9. Short KR, Kroeze EJ, Fouchier RA, KuikenT. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis 2014;14(1):57–69.):1566–1580.
  10. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med.2005;11:875–879. doi:10.1038/nm1267